Sector Gamma AS
- SEC CIK
- 0001475373
- Latest filing
- Aug 12, 2026
Holdings in Q2 2023
Holdings as of Jun 30, 2023, filed Aug 9, 2023. Long positions only; changes compare share counts with Q1 2023.
- Positions
- 29
- −2 vs. Q1 2023
- Portfolio value
- $446.9M
- +$34.4M (+8.4%) vs. Q1 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| GILDGilead Sciences, Inc. | Stock | 601,367 | $46.3M | 10.4% | +58,594+10.8% | Added | History |
| CAHCardinal Health Inc | Stock | 384,642 | $36.4M | 8.1% | +7,941+2.1% | Added | History |
| BMYBristol Myers Squibb Co | Stock | 507,576 | $32.5M | 7.3% | +58,005+12.9% | Added | History |
| MDTMedtronic plc | Stock | 346,508 | $30.5M | 6.8% | +27,604+8.7% | Added | History |
| BIIBBiogen Inc. | COM | 95,757 | $27.3M | 6.1% | +7,921+9.0% | Added | History |
| INCYIncyte Corp | COM | 397,532 | $24.7M | 5.5% | −34,703−8.0% | Reduced | History |
| BDXBecton Dickinson & Co | Stock | 92,923 | $24.5M | 5.5% | +92,923 | New | History |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 148,812 | $21.7M | 4.8% | −27,291−15.5% | Reduced | History |
| BAXBaxter International Inc | Stock | 473,634 | $21.6M | 4.8% | +306,634+183.6% | Added | History |
| EWEdwards Lifesciences Corp | Stock | 195,291 | $18.4M | 4.1% | +36,485+23.0% | Added | History |
| LHLabcorp Holdings Inc. | COM NEW | 73,104 | $17.6M | 3.9% | −8,311−10.2% | Reduced | History |
| CNCCentene Corp | Stock | 244,949 | $16.5M | 3.7% | +6,203+2.6% | Added | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 162,668 | $14.1M | 3.2% | +6,318+4.0% | Added | History |
| ELVElevance Health, Inc. | Stock | 31,351 | $13.9M | 3.1% | −4,428−12.4% | Reduced | History |
| THCTenet Healthcare Corp | COM NEW | 161,457 | $13.1M | 2.9% | −3,770−2.3% | Reduced | History |
| GEHCGE HealthCare Technologies Inc. | Stock | 151,328 | $12.3M | 2.8% | +151,328 | New | History |
| NUVANuvasive Inc | COM | 266,370 | $11.1M | 2.5% | +32,614+14.0% | Added | History |
| BRKRBruker Corp | COM | 112,242 | $8.30M | 1.9% | −40,875−26.7% | Reduced | History |
| CTLTCatalent, Inc. | COM | 180,088 | $7.81M | 1.7% | +29,587+19.7% | Added | History |
| IONSIonis Pharmaceuticals Inc | COM | 160,401 | $6.58M | 1.5% | +13,960+9.5% | Added | History |
| AMEDAmedisys Inc | COM | 71,007 | $6.49M | 1.5% | +71,007 | New | History |
| QGENQiagen N.V. | SHS NEW | 127,526 | $5.74M | 1.3% | −133,261−51.1% | Reduced | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 28,067 | $5.33M | 1.2% | +678+2.5% | Added | History |
| ACADAcadia Pharmaceuticals Inc | COM | 200,696 | $4.81M | 1.1% | −32,022−13.8% | Reduced | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 100,605 | $4.64M | 1.0% | −5,677−5.3% | Reduced | History |
| JNJJohnson & Johnson | Stock | 26,471 | $4.38M | 1.0% | +26,471 | New | History |
| LNTHLantheus Holdings, Inc. | Stock | 50,309 | $4.22M | 0.9% | +50,309 | New | History |
| VIRVir Biotechnology, Inc. | COM | 150,406 | $3.69M | 0.8% | +4,861+3.3% | Added | History |
| PTCTPTC Therapeutics, Inc. | COM | 56,577 | $2.30M | 0.5% | +1,671+3.0% | Added | History |
Sold out since Q1 2023 (7)
Positions held at the end of Q1 2023 that are gone from this filing.
| Security | Class | Shares in Q1 2023 | Value in Q1 2023 | % of portfolio in Q1 2023 | History |
|---|---|---|---|---|---|
| BSXBoston Scientific Corp | Stock | 162,397 | $8.12M | 2.0% | History |
| SGENSeagen Inc. | COM | 36,000 | $7.29M | 1.8% | History |
| BIOBio-Rad Laboratories, Inc. | CL A | 13,617 | $6.52M | 1.6% | History |
| MRKMerck & Co., Inc. | Stock | 56,153 | $5.97M | 1.4% | History |
| ILMNIllumina, Inc. | COM | 23,677 | $5.51M | 1.3% | History |
| BNTXBioNTech SE | SPONSORED ADS | 26,554 | $3.31M | 0.8% | History |
| CVSCVS Health Corp | Stock | 38,310 | $2.85M | 0.7% | History |